Covered recipient · General Payments record
RENEE DARLENE JOSEPH
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,155.96
- Reported across 124 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $691.18 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $246.04 | 11 |
| Lilly USA, LLC | $132.43 | 8 |
| Novo Nordisk AS | $80.82 | 5 |
| Amgen Inc. | $63.59 | 4 |
| Abbott Laboratories | $40.65 | 2 |
| ABIOMED | $23.25 | 1 |
| SANOFI-AVENTIS U.S. LLC | $23.17 | 1 |
| Stemline Therapeutics Inc. | $19.11 | 1 |
| Dynavax Technologies Corporation | $16.41 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.85 | 1 |
| Astellas Pharma US Inc | $15.07 | 1 |
| DEXCOM, INC. | $14.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $22.57 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125111455 | CMS |
| Abbott Laboratories | $18.08 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125111457 | CMS |
| ABBVIE INC. | $11.18 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104012704 | CMS |
| ABBVIE INC. | $23.34 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104012706 | CMS |
| ABBVIE INC. | $13.86 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104012708 | CMS |
| ABBVIE INC. | $9.05 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104012710 | CMS |
| ABBVIE INC. | $10.88 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104012712 | CMS |
| ABBVIE INC. | $125.00 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104012714 | CMS |
| ABBVIE INC. | $12.83 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104012716 | CMS |
| ABBVIE INC. | $9.66 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104012718 | CMS |
| ABBVIE INC. | $10.87 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104012720 | CMS |
| ABBVIE INC. | $13.52 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104012722 | CMS |
| ABBVIE INC. | $5.85 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104012724 | CMS |
| ABIOMED | $23.25 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142217490 | CMS |
| Amgen Inc. | $13.33 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117591871 | CMS |
| Amgen Inc. | $17.61 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117591873 | CMS |
| Amgen Inc. | $16.19 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117591875 | CMS |
| Amgen Inc. | $16.46 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117591877 | CMS |
| Astellas Pharma US Inc | $15.07 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139369525 | CMS |
| Dexcom, Inc. | $14.79 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153330371 | CMS |
| Dynavax Technologies Corporation | $16.41 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082144945 | CMS |
| Lilly USA, LLC | $12.65 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135364371 | CMS |
| Lilly USA, LLC | $23.85 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135333472 | CMS |
| Lilly USA, LLC | $11.45 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135353048 | CMS |
| Lilly USA, LLC | $28.48 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135363095 | CMS |
| Lilly USA, LLC | $14.64 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135383079 | CMS |
| Lilly USA, LLC | $17.59 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135333476 | CMS |
| Lilly USA, LLC | $12.43 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135384871 | CMS |
| Lilly USA, LLC | $11.34 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135353046 | CMS |
| Novartis Pharmaceuticals Corporation | $15.85 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086985428 | CMS |
| Novo Nordisk Inc | $14.42 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097264703 | CMS |
| Novo Nordisk Inc | $19.80 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097213195 | CMS |
| Novo Nordisk Inc | $15.91 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097374166 | CMS |
| Novo Nordisk Inc | $15.14 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097520532 | CMS |
| Novo Nordisk Inc | $15.55 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097302159 | CMS |
| SANOFI-AVENTIS U.S. LLC | $23.17 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139867628 | CMS |
| Stemline Therapeutics Inc. | $19.11 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142963378 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.